Bioanalysis of drop out/ Withdrawal subjects for Health Canada submission [Bioanalytics]

posted by shreyas goswami  – India, 2024-06-01 13:13 (18 d 00:07 ago) – Posting: # 24013
Views: 862

Dear Members,

As per text stated in "Guidance Document: Conduct and Analysis of Comparative Bioavailability Studies" for Health Canada," If a subject withdraws from the study for personal reasons or because of non-compliance with the protocol (e.g., positive drug test) before completing at least two periods of the study, the subject’s blood samples do not have to be analysed."

What can be the consequences if drop out subjects due to personal reason or protocol non-compliance are been analyzed during bioanalytical stage.

Can regulatory agency raise a query???? or any plausible significances occurs which leads to impact the study results.

Kindly, share your opinions.

Thanks in advance:-).

Shreyas Goswami.

Complete thread:

UA Flag
 Admin contact
23,057 posts in 4,840 threads, 1,641 registered users;
121 visitors (1 registered, 120 guests [including 11 identified bots]).
Forum time: 13:21 CEST (Europe/Vienna)

Even though it’s applied science we’re
dealin’ with, it still is – science!    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz